Reply

Journal of Pediatrics

Volumn 166, Issue 2, 2015, Pages 502-503

  Barrington, Keith J ^a   Janvier, Annie ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

DIET SUPPLEMENTATION; DRUG CONTROL; DRUG SAFETY; GOOD MANUFACTURING PRACTICE; HUMAN; LETTER; NECROTIZING ENTEROCOLITIS; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; BIFIDOBACTERIUM; ENTEROCOLITIS, NECROTIZING; FEMALE; INFANT, PREMATURE, DISEASES; LACTOBACILLUS RHAMNOSUS; MALE; NEWBORN INTENSIVE CARE; PROCEDURES;

BIFIDOBACTERIUM; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INFANT, PREMATURE, DISEASES; INTENSIVE CARE, NEONATAL; LACTOBACILLUS RHAMNOSUS; MALE; PROBIOTICS;

EID: 84921450455     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.10.063     Document Type: Letter

References (2)

1. S.E. Jacobs, J.M. Tobin, G.F. Opie, S. Donath, S.N. Tabrizi, and M. Pirotta Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial Pediatrics 132 2013 1055 1062
2. C. Hartel, J. Pagel, J. Rupp, M. Bendiks, F. Guthmann, and E. Rieger-Fackeldey Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants J Pediatrics 165 2014 285 289.e1